RT Book, Section
A1 Brewster, Wendy R.
A1 Tewari, Krishnansu S.
A2 Karlan, Beth Y.
A2 Bristow, Robert E.
A2 Li, Andrew J.
SR Print(0)
ID 1106569530
T1 Epidemiology of Gynecologic Cancers, Clinical Trials, and Statistical Considerations
T2 Gynecologic Oncology: Clinical Practice and Surgical Atlas
YR 2015
FD 2015
PB McGraw-Hill Medical
PP New York, NY
SN 9780071749268
LK hemonc.mhmedical.com/content.aspx?aid=1106569530
RD 2024/04/19
AB The  burden  of  cancer  on  our  population  is  expected  to  rise  sharply  over  the  next  20  years.  This  is  the  result  of  the  aging  and  growth  of  the  world's  population,  alongside  an  increasing  adoption  of  cancer-causing  behaviors,  particularly  smoking  and  increasing  obesity.  Overall,  cancer  incidence  is  expected  to  increase  by  45%  between  2010  and  2030,  with  the  greatest  increase  borne  by  older  adults  and  minorities.  By  2030,  approximately  70%  of  all  cancers  will  be  diagnosed  in  older  adults,  and  28%  of  all  cancers  will  be  diagnosed  in  minorities.1  Resources  will  be  required  to  effect  and  optimize  cancer  prevention,  screening,  and  early  detection.  Meaningful  improvements  in  cancer  therapy  and/or  prevention  strategies  will  be  required  to  prevent  a  dramatic  increase  in  the  number  of  cancer  deaths  over  the  next  20  years.